Serial #98609776
LIVE

Serial Number

98609776

Owner

Fresenius Kabi Deutschland GmbH

Attorney

Scott D. Woldow

Filing Date

Jun 20, 2024

Add to watchlist:

No watchlists yet
View on USPTO

Serial #98609776 Trademark

Serial Number: 98609776

Serial #98609776 is a trademark filed by Fresenius Kabi Deutschland GmbH on June 20, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Fresenius Kabi Deutschland GmbH (65 trademarks)

Else-Kroener-Str. 1
Bad Homburg 61352 , DE

Entity Type: 16

Trademark Details

Filing Date

June 20, 2024

Registration Date

Not Registered

Published for Opposition

February 4, 2025

Goods & Services

Pharmaceutical preparations for human use for the treatment of neurological diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, oncological diseases and disorders and viral infections; Pharmaceutical preparations for the treatment of autoimmune diseases, illnesses and conditions; Pharmaceutical preparations, namely, immunosuppressants; Pharmaceutical preparations for the treatment of plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, axial spondyloarthritis, polyarticular juvenile idiopathic arthritis and active enthesitis related arthritis, Crohn's disease, ulcerative colitis, hidradenitis colitis, hidradenitis suppurativa and non-infectious uveitis; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Biologics, namely, biological preparations for the treatment of neurological diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, oncological diseases and disorders and viral infections; Biologics, namely, biological preparations for the treatment of ankylosing spondylitis; Biological preparations for the treatment of and reducing signs and symptoms in adult patients with active ankylosing spondylitis; Protein therapeutics, namely, protein supplements; Pharmaceutical preparations for treating ankylosing spondylitis; Pharmaceutical preparations for the treatment of and for reducing signs and symptoms in adult patients with active ankylosing spondylitis

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2026 EXRA
SOU EXTENSION 2 GRANTED
Mar 3, 2026 EX2G
SOU EXTENSION 2 FILED
Mar 3, 2026 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 3, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 24, 2025 EXRA
SOU EXTENSION 1 GRANTED
Sep 24, 2025 EX1G
SOU EXTENSION 1 FILED
Sep 24, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 24, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 1, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 4, 2025 NPUB
PUBLISHED FOR OPPOSITION
Feb 4, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 29, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 15, 2025 CNSA
ASSIGNED TO EXAMINER
Jan 13, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jan 12, 2025 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 12, 2025 NWOS
NEW APPLICATION ENTERED
Jun 20, 2024 NWAP